• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射时,聚合物纳米载体与三磷酸腺苷混合后可增强其在视网膜中的转运和渗透。

Enhanced Transport and Permeation of a Polymeric Nanocarrier across the Retina by Mixing with ATP upon Intravitreal Injection.

作者信息

Kwon Kiyoon, Hwang Youngmin, Jung Junyoung, Tae Giyoong

机构信息

School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.

出版信息

Pharmaceutics. 2021 Mar 29;13(4):463. doi: 10.3390/pharmaceutics13040463.

DOI:10.3390/pharmaceutics13040463
PMID:33805533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8065980/
Abstract

The outer part of the retina pigment epithelium (RPE) in the retina is the main site of neovascularization associated with retinal diseases. However, various obstacles interrupt the delivery of medicines across the RPE, mainly due to the well-developed tight junctions in the RPE. Currently, there is no practical formulation to overcome this issue. In this study, we demonstrated that simple mixing with adenosine tetraphosphate (ATP) has the potential to greatly enhance the transport and permeation of a polymeric nanocarrier across the retina via intravitreal administration. Chitosan-functionalized, pluronic-based nanocarrier (NC), which can deliver various biomolecules efficiently, was used as a polymeric nanocarrier. Mixing with ATP facilitated the diffusion of the nanocarrier in the vitreous humor by reducing the electrostatic interaction between NC and negatively charged glycosaminoglycans (GAGs) in the vitreous humor. Mixing with ATP also allowed the penetration of NC across the whole retina, and it resulted in a great increase (approximately nine times) in the transport of NC across the retina, as well as spreading it throughout the whole retina upon intravitreal administration in a mouse model. This enhanced permeation across the retina was specific to ATP but not to GTP, suggesting the possibility of P2Y receptor-mediated tight junction disruption by ATP.

摘要

视网膜色素上皮(RPE)的外层是视网膜疾病相关新生血管形成的主要部位。然而,多种障碍阻碍了药物穿过RPE的递送,这主要是由于RPE中紧密连接发达。目前,尚无切实可行的制剂来克服这一问题。在本研究中,我们证明与四磷酸腺苷(ATP)简单混合有潜力通过玻璃体内给药极大地增强聚合物纳米载体在视网膜上的转运和渗透。壳聚糖功能化的、基于普朗尼克的纳米载体(NC)可有效递送各种生物分子,被用作聚合物纳米载体。与ATP混合通过减少NC与玻璃体内带负电荷的糖胺聚糖(GAGs)之间的静电相互作用促进了纳米载体在玻璃体内的扩散。与ATP混合还使NC能够穿透整个视网膜,并且在小鼠模型中玻璃体内给药后,导致NC在视网膜上的转运大幅增加(约九倍),并使其在整个视网膜中扩散。这种跨视网膜的增强渗透对ATP具有特异性,而对GTP不具有特异性,提示ATP介导P2Y受体破坏紧密连接的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/c774308b311d/pharmaceutics-13-00463-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/820c518ba208/pharmaceutics-13-00463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/69e4da8f669a/pharmaceutics-13-00463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/c1d0940b64c6/pharmaceutics-13-00463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/337c8bcaa38c/pharmaceutics-13-00463-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/c774308b311d/pharmaceutics-13-00463-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/820c518ba208/pharmaceutics-13-00463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/69e4da8f669a/pharmaceutics-13-00463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/c1d0940b64c6/pharmaceutics-13-00463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/337c8bcaa38c/pharmaceutics-13-00463-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac5/8065980/c774308b311d/pharmaceutics-13-00463-g005.jpg

相似文献

1
Enhanced Transport and Permeation of a Polymeric Nanocarrier across the Retina by Mixing with ATP upon Intravitreal Injection.玻璃体内注射时,聚合物纳米载体与三磷酸腺苷混合后可增强其在视网膜中的转运和渗透。
Pharmaceutics. 2021 Mar 29;13(4):463. doi: 10.3390/pharmaceutics13040463.
2
ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug.ZOT 衍生肽和壳聚糖功能化纳米载体用于口服递送蛋白质药物。
Biomaterials. 2016 Oct;103:160-169. doi: 10.1016/j.biomaterials.2016.06.059. Epub 2016 Jun 27.
3
Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation.视网膜色素上皮通透性在后节眼与全身血液循环药物转运中的作用。
Eur J Pharm Biopharm. 2019 Oct;143:18-23. doi: 10.1016/j.ejpb.2019.08.008. Epub 2019 Aug 13.
4
Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection.经玻璃体注射后体外牛视网膜中超声介导的纳米颗粒递释。
Eur J Pharm Biopharm. 2017 Oct;119:125-136. doi: 10.1016/j.ejpb.2017.06.009. Epub 2017 Jun 8.
5
Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection.共注射硫酸酪氨酸可促进玻璃体内注射后透明质酸纳米球在视网膜的摄取。
Pharmaceutics. 2021 Sep 18;13(9):1510. doi: 10.3390/pharmaceutics13091510.
6
Tuning surface functionalities of sub-10 nm-sized nanocarriers to target outer retina in designing drug delivery agents for intravitreal administration.在设计用于玻璃体内给药的药物递送剂时,调整尺寸小于10纳米的纳米载体的表面功能以靶向视网膜外层。
Biomaterials. 2020 Oct;255:120188. doi: 10.1016/j.biomaterials.2020.120188. Epub 2020 Jun 15.
7
Tight Junctions of the Outer Blood Retina Barrier.外周血视网膜屏障的紧密连接。
Int J Mol Sci. 2019 Dec 27;21(1):211. doi: 10.3390/ijms21010211.
8
A Multifunctional Hybrid Nanocarrier for Non-Invasive siRNA Delivery to the Retina.一种用于将小干扰RNA无创递送至视网膜的多功能混合纳米载体。
Pharmaceutics. 2023 Feb 11;15(2):611. doi: 10.3390/pharmaceutics15020611.
9
Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.用透明质酸包覆纳米载体有助于视网膜基因治疗的玻璃体内药物递送。
J Control Release. 2015 Mar 28;202:83-92. doi: 10.1016/j.jconrel.2015.01.030. Epub 2015 Jan 26.
10
Can ultrasound solve the transport barrier of the neural retina?超声能解决神经视网膜的转运障碍吗?
Pharm Res. 2008 Nov;25(11):2657-65. doi: 10.1007/s11095-008-9684-2. Epub 2008 Jul 23.

引用本文的文献

1
Recent Achievements and Perspectives in Smart Nano-in-Micro Platforms for Ocular Disease Treatment.用于眼部疾病治疗的智能微纳平台的最新成果与展望
Int J Nanomedicine. 2025 Jun 17;20:7579-7612. doi: 10.2147/IJN.S518643. eCollection 2025.
2
Recent Advances in Ophthalmic Drug Delivery.眼科药物递送的最新进展
Pharmaceutics. 2022 Sep 29;14(10):2075. doi: 10.3390/pharmaceutics14102075.

本文引用的文献

1
Nanocarriers for ocular drug delivery: current status and translational opportunity.用于眼部药物递送的纳米载体:现状与转化机遇
RSC Adv. 2020 Jul 24;10(46):27835-27855. doi: 10.1039/d0ra04971a. eCollection 2020 Jul 21.
2
Extracellular ATP modulates podocyte function through P2Y purinergic receptors and pleiotropic effects on AMPK and cAMP/PKA signaling pathways.细胞外 ATP 通过 P2Y 嘌呤能受体调节足细胞功能,对 AMPK 和 cAMP/PKA 信号通路产生多效性影响。
Arch Biochem Biophys. 2020 Nov 30;695:108649. doi: 10.1016/j.abb.2020.108649. Epub 2020 Oct 22.
3
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations.
眼部后段给药:生物药剂学和药代动力学考量
Pharmaceutics. 2020 Mar 16;12(3):269. doi: 10.3390/pharmaceutics12030269.
4
Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia.透明质酸包覆白蛋白纳米粒靶向递肽治疗视网膜缺血。
Biomaterials. 2018 Jun;168:10-23. doi: 10.1016/j.biomaterials.2018.03.034. Epub 2018 Mar 20.
5
Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.眼部给药屏障——纳米载体在眼前节眼部疾病治疗中的作用
Pharmaceutics. 2018 Feb 27;10(1):28. doi: 10.3390/pharmaceutics10010028.
6
Purinergic Signalling: Therapeutic Developments.嘌呤能信号传导:治疗进展
Front Pharmacol. 2017 Sep 25;8:661. doi: 10.3389/fphar.2017.00661. eCollection 2017.
7
Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone).与氧化应激相关的视网膜疾病及自由基清除剂(依达拉奉)的作用
Oxid Med Cell Longev. 2017;2017:9208489. doi: 10.1155/2017/9208489. Epub 2017 Jan 18.
8
Pharmacokinetic aspects of retinal drug delivery.视网膜药物递送的药代动力学方面。
Prog Retin Eye Res. 2017 Mar;57:134-185. doi: 10.1016/j.preteyeres.2016.12.001. Epub 2016 Dec 24.
9
ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug.ZOT 衍生肽和壳聚糖功能化纳米载体用于口服递送蛋白质药物。
Biomaterials. 2016 Oct;103:160-169. doi: 10.1016/j.biomaterials.2016.06.059. Epub 2016 Jun 27.
10
Tight junctions: from simple barriers to multifunctional molecular gates.紧密连接:从简单的屏障到多功能分子门控。
Nat Rev Mol Cell Biol. 2016 Sep;17(9):564-80. doi: 10.1038/nrm.2016.80. Epub 2016 Jun 29.